MEBUTAMATE


Trade Names	DORMATE
Synonyms	Axiten Butatensin Carbuten Dicamoylmethane Dormate Encapla Ipotensivo Mebutamat Mebutamate Mebutina Mioartrina NSC-163921 Prean Preminex Sigmafon Vallene W-583
Status
Molecule Category	UNKNOWN
ATC	N05BC04
UNII	5H8F175RER
EPA CompTox	DTXSID1023239


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	LEROTMJVBFSIMP-UHFFFAOYSA-N
Smiles	CCC(C)C(C)(COC(N)=O)COC(N)=O
InChI	InChI=1S/C10H20N2O4/c1-4-7(2)10(3,5-15-8(11)13)6-16-9(12)14/h7H,4-6H2,1-3H3,(H2,11,13)(H2,12,14)

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C10H20N2O4
Molecular Weight	232.28
AlogP	1.23
Hydrogen Bond Acceptor	4.0
Hydrogen Bond Donor	2.0
Number of Rotational Bond	6.0
Polar Surface Area	104.64
Molecular species	NEUTRAL
Aromatic Rings	0.0
Heavy Atoms	16.0

Related Entries

Cross References

Resources	Reference
ChEBI	31804
ChEMBL	CHEMBL1200922
DrugBank	DB06797
DrugCentral	1644
FDA SRS	5H8F175RER
PubChem	6151
SureChEMBL	SCHEMBL122289

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).